Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tenet Healthcare Corporation (THC) vs TJX Companies Inc (TJX) Price & Performance

Tenet Healthcare CorporationTrade
TJX Companies IncTrade

Price performance (Past 24H)

Key statistics

Tenet Healthcare Corporation vs TJX Companies Inc — how do they compare? Tenet Healthcare Corporation trades at $269.36 (market cap $20.86B), while TJX Companies Inc trades at $126.69 (market cap $141.81B). The key difference: TJX Companies Inc is far larger — about 6.8× Tenet Healthcare Corporation's market cap, and TJX Companies Inc pays a 1.49% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.

THCTJX
Market Cap
$20.86B$141.81B
Sector
HealthConsumer Cyclical
52-Week High
$280.77$168.41
52-Week Low
$161.37$126.10
Enterprise Value
$31.94B$150.12B
Dividend Yield
1.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.06, down 2.26% today, with a bearish technical signal but strong fundamentals. The stock exhibits robust profitability with an 82.83% gross margin and 53.31% ROE, supported by three consecutive quarterly EPS beats. Recent news includes a $2.0 billion senior notes offering for refinancing and participation in the Wells Fargo Healthcare Conference.

Outlook remains positive given analyst consensus of 81.25% buy ratings and a $281.44 price target, implying 8.6% upside. Risks include debt refinancing execution and healthcare regulatory pressures, but earnings momentum and valuation multiples below industry averages present a compelling opportunity for value investors.

TJX Companies Inc

TJX Companies (TJX) trades at $128.91, down 2.4% over 24 hours, with technical indicators showing bearish momentum but oversold RSI signals. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.22 exceeding expectations. Revenue grew to $56.36 billion in 2025, and net income margin improved to 9.73%. Analysts maintain a bullish consensus with 84.6% buy ratings and a $169 price target, citing expansion plans to 7,500 stores.

The outlook for TJX is positive due to consistent earnings outperformance and robust store growth strategy, though near-term stock pressure reflects valuation concerns and competitive comparisons. Key risks include market volatility and execution challenges in scaling operations. Investors may find opportunity in the current dip given strong fundamentals and analyst support.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC

About TJX Companies Inc

TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.

Read more on TJX